Clinical Trial Update: hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating hematopoietic stem cell rescue for glioblastoma (hSTAR GBM) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Hematopoietic stem cell rescue (hSTAR)

Snippet

Sponsor: Leland Metheny | Conditions: Glioblastoma Multiforme, Glioblastoma Multiforme, Adult | Phase 2 | Status: RECRUITING